Many radiomics studies have investigated the capability for analyzing thyroid carcinoma, including prediction of distant metastases of follicular thyroid carcinoma [14], risk stratification systems for thyroid nodules [15], the differentiation between malignancy and benign thyroid nodules [25], prediction of lymph nodes status [18–21], prediction of BRAF mutation [26], prediction of malignancy and pathological outcome in patients with papillary thyroid cancer [27]. The gene discussed is BRAF; the disease is thyroid nodule.